Murphy Sean V, Atala Anthony
Wake Forest Institute for Regenerative Medicine, Wake Forest University Health Sciences, Winston-Salem, NC, USA.
J Tissue Eng Regen Med. 2015 Mar;9(3):210-23. doi: 10.1002/term.1746. Epub 2013 Jul 25.
Currently there is no cure for cystic fibrosis (CF). Treatments are focused on addressing the disease symptoms, with varying degrees of success. Regenerative medicine holds the promise of regenerating dysfunctional or damaged tissues and to enhance the body's own endogenous repair mechanisms. The discovery of endogenous and exogenous stem cells has provided valuable tools for development of novel treatments for CF. The ability of stem cells to differentiate into functional pulmonary cells, modulate inflammatory responses and contribute to pulmonary function has provided researchers with multiple approaches to develop effective treatment strategies. Several approaches show promise to produce viable therapeutic treatments to treat the underlying cause of CF, reduce the symptoms and mitigate long-term damage, and generate functional replacement organs for end-stage transplantation. This review provides an overview of the rapidly progressing field of cell therapy for CF, focusing on the various cell types utilized and current strategies that show promise to improve life expectancy and quality of life for CF patients.
目前,囊性纤维化(CF)尚无治愈方法。治疗主要集中在缓解疾病症状,且成效各异。再生医学有望使功能失调或受损的组织再生,并增强人体自身的内源性修复机制。内源性和外源性干细胞的发现为开发CF的新型治疗方法提供了宝贵工具。干细胞分化为功能性肺细胞、调节炎症反应以及促进肺功能的能力,为研究人员开发有效的治疗策略提供了多种途径。几种方法有望产生可行的治疗方案,以治疗CF的根本病因、减轻症状和缓解长期损害,并为终末期移植生成功能性替代器官。本综述概述了CF细胞治疗这一快速发展的领域,重点介绍了所使用的各种细胞类型以及目前有望提高CF患者预期寿命和生活质量的策略。